At the same time, we found that the p‐STAT3, VEGF, P‐gp and MRP1 expressions in the inflammatory microenvironment were elevated, indicating that the inflammatory microenvironment enhanced the drug resistance of SCLC by activating the STAT3/VEGF signaling pathway. The gene discussed is STAT3; the disease is small cell lung carcinoma.